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Quantitative measurement of hTERT mRNA in sera of the patients with 
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G. Okada, H. Watanabe, H. Mouri, K. Ohtsubo and N. Sawabu 
    Human telomerase reverse transcriptase (hTERT) is regarded as a catalytic component of 
telomerase and a rate-limiting determinant of the enzymatic activity of human telomerase. Its 
expression reflects the telomerase activity. Usually, telomerase is inactivated or its activity 
repressed in the majority of normal somatic cells but is activated in germ cells, embryonal cells, 
proliferating cells of renewable tissues, and activated lymphocytes as well as in most malignant 
tumor cells. We examined whether the detection of hTERT mRNA in sera by real-time RT-PCR 
is useful or not for the diagnosis of pancreatic carcinoma (PCa).  
    The serum samples were obtained from 16 patients with PCa, 4 with chronic pancreatitis 
(CP), and 23 healthy subjects and the RNA was extracted from the serum immediately and 
stored at –80℃ until the assay. The RNA samples were reverse-transcribed after DNase I 
treatment, and measured by the real-time RT-PCR. 
    The hTERT mRNA in sera was detected in 13 (57%) of the 23 control subjects and 16 
(100%) of 16 PCa patients by the real-time RT-PCR and the agarose gel electrophoresis. Based 
upon the standard curve using hTERT cDNA as a positive control, a linear relationship between 
PCR products and cycle number of hTERT cDNA was confirmed in the range from 0.03pg to 
30ng. A linear relationship about 18S rRNA was also confirmed by real-time RT-PCR. The mean
±SD of the ratio of hTERT mRNA X 10-2/18S in sera from the control subjects, patients with 
PCa, and patients with CP was 0.07±0.18, 0.13±0.25, and 0.002±0.05, respectively. With a 
standard value of 0.07 as the mean value of normal subjects, 3 (13%) of 23 normal subjects, 6 
(38%) of 16 patients with PCa, and none (0%) of 4 with CP showed elevated values. The PCa 
patients with the high values of hTERT mRNA/18S in sera showed advanced clinical stages 
such as liver metastasis and peritoneal dissemination, whereas some of the PCa patients with its 
low value less than 0.07 in sera underwent surgical resection and obtained longer survival.  
However, the values of hTERT mRNA/18S in sera were elevated in a part of normal subjects as 
well as PCa patients. Moreover, the values of hTERT mRNA/18S with PCa patients 
considerably overlapped with those with normal subjects even in the high range. It is probably 
because the hTERT mRNA derived from proliferating cells of renewal tissues or activated 
lymphocytes may be included in the serum. Therefore, assay of hTERT mRNA in the serum may 
be troublesome and not useful for the clinical application from the results of our study although 
hTERT mRNA has been reportedly supposed to be a useful tumor marker. 
 
